Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COL7A1 Editing via RNA Trans-Splicing in RDEB-Derived Skin Equivalents.
Liemberger B, Bischof J, Ablinger M, Hainzl S, Murauer EM, Lackner N, Ebner P, Kocher T, Nyström A, Wally V, Mayr E, Guttmann-Gruber C, Hofbauer JP, Bauer JW, Koller U. Liemberger B, et al. Among authors: nystrom a. Int J Mol Sci. 2023 Feb 22;24(5):4341. doi: 10.3390/ijms24054341. Int J Mol Sci. 2023. PMID: 36901775 Free PMC article.
Collagen VII plays a dual role in wound healing.
Nyström A, Velati D, Mittapalli VR, Fritsch A, Kern JS, Bruckner-Tuderman L. Nyström A, et al. J Clin Invest. 2013 Aug;123(8):3498-509. doi: 10.1172/JCI68127. Epub 2013 Jul 8. J Clin Invest. 2013. PMID: 23867500 Free PMC article.
A Gene Gun-mediated Nonviral RNA trans-splicing Strategy for Col7a1 Repair.
Peking P, Koller U, Hainzl S, Kitzmueller S, Kocher T, Mayr E, Nyström A, Lener T, Reichelt J, Bauer JW, Murauer EM. Peking P, et al. Among authors: nystrom a. Mol Ther Nucleic Acids. 2016 Mar 1;5:e287. doi: 10.1038/mtna.2016.3. Mol Ther Nucleic Acids. 2016. PMID: 26928235 Free article.
RNA-based therapies for genodermatoses.
Bornert O, Peking P, Bremer J, Koller U, van den Akker PC, Aartsma-Rus A, Pasmooij AM, Murauer EM, Nyström A. Bornert O, et al. Among authors: nystrom a. Exp Dermatol. 2017 Jan;26(1):3-10. doi: 10.1111/exd.13141. Exp Dermatol. 2017. PMID: 27376675 Free PMC article. Review.
QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study.
Bornert O, Hogervorst M, Nauroy P, Bischof J, Swildens J, Athanasiou I, Tufa SF, Keene DR, Kiritsi D, Hainzl S, Murauer EM, Marinkovich MP, Platenburg G, Hausser I, Wally V, Ritsema T, Koller U, Haisma EM, Nyström A. Bornert O, et al. Among authors: nystrom a. J Invest Dermatol. 2021 Apr;141(4):883-893.e6. doi: 10.1016/j.jid.2020.08.018. Epub 2020 Sep 16. J Invest Dermatol. 2021. PMID: 32946877 Free article.
280 results